Human monocyte responses to lipopolysaccharide and 9-cis retinoic acid after laparoscopic surgery for colon cancer

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 8, 2012, Pages 593-601

  Kolseth, Ingrid B M ^a,b   Forland, Dag T ^c   Risoe, Petter K ^a,b   Flood Kjeldsen, Signe ^a   Ågren, Joanna ^a,b   Reseland, Janne E ^b   Lyngstadaas, Staale P ^b   Johnson, Egil ^c   Dahle, Maria K ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

chemokines; Cytokines; gastrointestinal cancer surgery; monocytes; suppressor of cytokine signaling

Indexed keywords

ALITRETINOIN; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; COLORECTAL SURGERY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INFLAMMATION; LAPAROSCOPIC SURGERY; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LAPAROSCOPY; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TREATMENT OUTCOME; TRETINOIN;

BACTERIA (MICROORGANISMS);

EID: 84869426696     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.721520     Document Type: Article

References (41)

1. Ni CN., Redmond HP. Cell response to surgery. Arch Surg 2006; 141: 1132-40. (Pubitemid 44790546)
2. Wichmann MW., Hüttl TP., Winter H., Spelsberg F., Angele MK., Heiss MM., Jauch KW. Immunological effects of laparoscopic vs open colorectal surgery: a prospective clinical study. Arch Surg 2005; 140: 692-7. (Pubitemid 41124008)
3. Maxwell-Armstrong CA., Robinson MH., Scholefield JH. Laparoscopic colorectal cancer surgery. Am J Surg 2000; 179: 500-7.
4. COLOR study group. COLOR:a randomized clinical trial comparing laparoscopic and open resection for colon cancer. Dig Surg 2000; 17: 617-22.
5. Remick DG., Call DR., Ebong SJ Newcomb DE., Nybom P., Nemzek JA., Bolgos GE. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit Care Med 2001; 29: 473-81. (Pubitemid 32225286)
6. Moser R., Schleiffenbaum B., Groscurth P., Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1989; 83: 444-55. (Pubitemid 19061163)
7. Toniatti C., Arcone R., Majello B., Ganter U., Arpaia G., Ciliberto G. Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. Mol Biol Med 1990; 7: 199-212. (Pubitemid 20283933)
8. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86. (Pubitemid 39457982)
9. Laudanski K., Wyczechowska D. Monocyte-related immunopathologies in trauma patients. Arch Immunol Ther Exp (Warsz) 2005; 53: 321-8. (Pubitemid 43186760)
10. Martinez FO., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-11. (Pubitemid 44715100)
11. Mansell A., Smith R., Doyle SL., Gray P., Fenner JE., Crack PJ., Nicholson SE., Hilton DJ., O'Neill LA., Hertzog PJ. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006; 7: 148-55. (Pubitemid 43135880)
12. Fang M., Dai H., Yu G., Gong F. Gene delivery of SOCS3 protects mice from lethal endotoxic shock. Cell Mol Immunol 2005; 2: 373-7.
13. Xu J., Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol 2006; 171: 135-44. (Pubitemid 41832284)
14. Kolseth IB., Agren J., Sundvold-Gjerstad V., Lyngstadaas SP., Wang JE., Dahle MK. 9-cis retinoic acid inhibits inflammatory responses of adherent monocytes and increases their ability to induce classical monocyte migration. J Innate Immun 2012; 4: 176-86.
15. Desvergne B. RXR: from partnership to leadership in metabolic regulations. Vitam Horm 2007; 75: 1-32.
16. Barish GD. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity. J Nutr 2006; 136: 690-4. (Pubitemid 43363755)
17. Castrillo A., Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Devel Biol 2004; 20: 455-80. (Pubitemid 39488646)
18. Yamazaki K., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Kanemura N., Araki H., Tsurumi H., Kojima S., Weinstein IB., Moriwaki H. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells-phosphorylated RXR alpha is a critical target for colon cancer management. Gut 2007; 56: 1557-63. (Pubitemid 350033194)
19. Jacobs ET., Martinez ME., Campbell PT., Conti DV., Duggan D., Figueiredo JC., Haile RW., LeRoy EC., Poynter JN., Thompson PA., Baron JA. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2010; 31: 1412-6.
20. Egan JB., Thompson PA., Ashbeck EL., Conti DV., Duggan D., Hibler E., Jurutka PW., Leroy EC., Martínez ME., Mount D., Jacobs ET. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 2010; 70: 1496-504.
21. Chung YC., Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 2003; 83: 222-6.
22. Galizia G., Orditura M., Romano C., Lieto E., Castellano P., Pelosio L., Imperatore V., Catalano G., Pignatelli C., De Vita F. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002; 102: 169-78. (Pubitemid 34171516)
23. Wang JE., Solberg R., Okkenhaug C., Jorgensen PF., Krohn CD., Aasen AO. Cytokine modulation in experimental endotoxemia: characterization of an ex vivo whole blood model. Eur Surg Res 2000; 32: 65-73. (Pubitemid 30251764)
24. Wang JE., Jorgensen PF., Almlof M., Thiemermann C., Foster SJ., Aasen AO., Solberg R. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infection Immunity 2000; 68: 3965-70. (Pubitemid 30434548)
25. Na SY., Kang BY., Chung SW., Han SJ., Ma X., Trinchieri G., Im SY., Lee JW., Kim TS. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem 1999; 274: 7674-80.
26. Delgado S., Lacy AM., Filella X., Castells A., García-Valdecasas JC., Pique JM., Momblán D., Visa J. Acute phase response in laparoscopic and open colectomy in colon cancer: randomized study. Dis Colon Rectum 2001; 44: 638-46. (Pubitemid 32428710)
27. Hildebrandt U., Kessler K., Plusczyk T., Pistorius G., Vollmar B., Menger MD. Comparison of surgical stress between laparoscopic and open colonic resections. Surg Endosc 2003; 17: 242-6. (Pubitemid 36173275)
28. Paduch R., Kandefer-Szerszen M., Piersiak T. The importance of release of proinflammatory cytokines, ROS, and NO in different stages of colon carcinoma growth and metastasis after treatment with cytotoxic drugs. Oncol Res 2010; 18: 419-36.
29. Yoshimura A., Nishinakamura H., Matsumura Y., Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005; 7: 100-10. (Pubitemid 40775170)
30. Whyte CS., Bishop ET., Ruckerl D., Gaspar-Pereira S., Barker RN., Allen JE., Rees AJ., Wilson HM. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol 2011; 90: 845-54.
31. Starr R., Hilton DJ. SOCS: suppressors of cytokine signalling. Int J Biochem Cell Biol 1998; 30: 1081-5. (Pubitemid 28484830)
32. Wormald S., Zhang JG., Krebs DL., Mielke LA., Silver J., Alexander WS., Speed TP., Nicola NA., Hilton DJ. The comparative roles of suppressor of cytokine signaling-1 and-3 in the inhibition and desensitization of cytokine signaling. J Biol Chem 2006; 281: 11135-43. (Pubitemid 43855538)
33. Berlato C., Cassatella MA., Kinjyo I., Gatto L., Yoshimura A., Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002; 168: 6404-11. (Pubitemid 34620065)
34. Niemand C., Nimmesgern A., Haan S., Fischer P., Schaper F., Rossaint R., Heinrich PC., Müller-Newen G. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170: 3263-72. (Pubitemid 36302204)
35. Bhattacharyya S., Zhao Y., Kay TW., Muglia LJ. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc Natl Acad Sci USA 2011; 108: 9554-9.
36. Levin AA., Sturzenbecker LJ., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo JH. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 1992; 355: 359-61.
37. Shimizu M., Moriwaki H. Synergistic effects of PPARgamma ligands and retinoids in cancer treatment. PPAR Res 2008; 181047.
38. Wang X., Allen C., Ballow M. Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol 2007; 27: 193-200. (Pubitemid 46348724)
39. Deshmane SL., Kremlev S., Amini S., Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313-26.
40. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006; 116: 607-14. (Pubitemid 43326865)
41. Zhu L., Bisgaier CL., Aviram M., Newton RS. 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Arterioscler Thromb Vasc Biol 1999; 19: 2105-11. (Pubitemid 29422241)